Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension

Boiko Olha, Olena Kovalenko, Viktoriia Rodionova
European Respiratory Journal 2021 58: PA3838; DOI: 10.1183/13993003.congress-2021.PA3838
Boiko Olha
1SI DMA, Dnipro, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Olhashev93@gmail.com
Olena Kovalenko
1SI DMA, Dnipro, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Viktoriia Rodionova
1SI DMA, Dnipro, Ukraine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Arterial hypertension (H) is the most common comorbidity in COPD. An increase in the level of C-reactive protein (CRP) is associated with an increase in cardiovascular risk (CVR) in patients with H. The aim of the study was to identify the relationship between the level of CRP and the total 10-year (tCVR) in stable comorbid patients with COPD and H.

Materials and methods: The study included 83 patients. Group I (I) - 42 stable patients with COPD with H stage II, group II (II) - 41 patients with H stage II. The calculation of the tCVR, determination of CRP (enzyme-linked immunosorbent assay), spirometry was carried out.

Results: In I the average age (56.0 ± 6.7) years, the tCVR was 5.92[2.58; 10.61]%. Average age in II - (56.9 ± 5.8), total CVR - 5.85 [2.18; 11.48]%. The CRP in I (5.61 [2.55; 10.81] mg /l) was higher than in II (3.67 [1.44; 5.30]), p=0.048. In I the CRP had a negative correlation with the FEV1/FVC (R = -0.50, p=0.001). The CRP in patients of I with FEV1=50% (3.6 [1.55; 10.8] mg/l) did not differ from II, but was significantly lower than in patients with FEV1

Conclusions: Increased CRP level in stable comorbid patients with COPD and H is predominantly due to brochoobstruction.While in H, an increase in CBR has a direct relationship with the index of tCVR, in stable patients with comorbidity of COPD and H such a relationship was established only in patients with FEV1 = 50%.

Footnotes

Cite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3838.

This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2021
Previous
Back to top
Vol 58 Issue suppl 65 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Boiko Olha, Olena Kovalenko, Viktoriia Rodionova
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3838; DOI: 10.1183/13993003.congress-2021.PA3838

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
LSC - 2021 - The relationship between the level of C-reactive protein and the general cardiovascular risk in patients with COPD and hypertension
Boiko Olha, Olena Kovalenko, Viktoriia Rodionova
European Respiratory Journal Sep 2021, 58 (suppl 65) PA3838; DOI: 10.1183/13993003.congress-2021.PA3838
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Late Breaking Abstract - The SF-36 quality of life scales are sensitive measures of lung function decline
  • Usefullnes of chest computed tomography as a tool to predict COPD exacerbations
  • Late Breaking Abstract - Adrenal function improvement after oral corticosteroid reduction in benralizumab-treated severe eosinophilic asthma: PONENTE maintenance phase
Show more Monitoring airway disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society